Literature DB >> 18243579

Drug use and other risk factors related to lower body mass index among HIV-infected individuals.

Lien A Quach1, Christine A Wanke, Christopher H Schmid, Sherwood L Gorbach, D Mkaya Mwamburi, Kenneth H Mayer, Donna Spiegelman, Alice M Tang.   

Abstract

Malnutrition is associated with morbidity and mortality in HIV-infected individuals. Little research has been conducted to identify the roles that clinical, illicit drug use and socioeconomic characteristics play in the nutritional status of HIV-infected patients. This cross-sectional analysis included 562 HIV-infected participants enrolled in the Nutrition for Healthy Living study conducted in Boston, MA and Providence, RI. The relationship between body mass index (BMI) and several covariates (type of drug use, demographic, and clinical characteristics) were examined using linear regression. Overall, drug users had a lower BMI than non-drug users. The BMI of cocaine users was 1.4 kg/m(2) less than that of patients who did not use any drugs, after adjusting for other covariates (p=0.02). The BMI of participants who were over the age of 55 years was 2.0 kg/m(2) less than that of patients under the age of 35, and BMI increased by 0.3 kg/m(2) with each 100 cells/mm(3) increase in CD4 count. HAART use, adherence to HAART, energy intake, AIDS status, hepatitis B and hepatitis C co-infections, cigarette smoking and depression were not associated with BMI in the final model. In conclusion, BMI was lower in drug users than non-drug users, and was lowest in cocaine users. BMI was also directly associated with CD4 count and inversely related to age more than 55 years old. HIV-infected cocaine users may be at higher risk of developing malnutrition, suggesting the need for anticipatory nutritional support.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243579      PMCID: PMC3837518          DOI: 10.1016/j.drugalcdep.2007.12.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  21 in total

1.  Nutrient intake and body weight in a large HIV cohort that includes women and minorities.

Authors:  Margo N Woods; Donna Spiegelman; Tamsin A Knox; Janet E Forrester; Joan L Connors; Sarah C Skinner; Marisela Silva; Jean H Kim; Sherwood L Gorbach
Journal:  J Am Diet Assoc       Date:  2002-02

2.  Prevalence and predictive value of overweight in an urban HIV care clinic.

Authors:  J Shuter; C J Chang; R S Klein
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

3.  Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy.

Authors:  Marijka J Batterham; Roger Garsia; Philippa Greenop
Journal:  Int J STD AIDS       Date:  2002-11       Impact factor: 1.359

4.  Body mass index at time of HIV diagnosis: a strong and independent predictor of survival.

Authors:  Marianne A B van der Sande; Maarten F Schim van der Loeff; Akum A Aveika; Saihou Sabally; Toyin Togun; Ramu Sarge-Njie; Abraham S Alabi; Assan Jaye; Tumani Corrah; Hilton C Whittle
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

5.  Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection.

Authors:  M Ott; H Fischer; H Polat; E B Helm; M Frenz; W F Caspary; B Lembcke
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-05-01

6.  Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection.

Authors:  I B Wilson; D L Jacobson; R Roubenoff; D Spiegelman; T A Knox; S L Gorbach
Journal:  HIV Med       Date:  2002-10       Impact factor: 3.180

7.  Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort.

Authors:  Clara Y Jones; Joseph W Hogan; Brad Snyder; Robert S Klein; Anne Rompalo; Paula Schuman; Charles C Carpenter
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

8.  Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients.

Authors:  U Süttmann; J Ockenga; O Selberg; L Hoogestraat; H Deicher; M J Müller
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-03-01

9.  Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy.

Authors:  Alice M Tang; Janet Forrester; Donna Spiegelman; Tamsin A Knox; Eric Tchetgen; Sherwood L Gorbach
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

10.  Development of a brief screening instrument for detecting depressive disorders.

Authors:  M A Burnam; K B Wells; B Leake; J Landsverk
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

View more
  27 in total

1.  Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior.

Authors:  Xiangru Xu; Mohamed R Mughal; F Scott Hall; Maria T G Perona; Paul J Pistell; Justin D Lathia; Srinivasulu Chigurupati; Kevin G Becker; Bruce Ladenheim; Laura E Niklason; George R Uhl; Jean Lud Cadet; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

2.  Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation.

Authors:  Gretchen E Volpe; Honorine Ward; Mkaya Mwamburi; Duy Dinh; Seema Bhalchandra; Christine Wanke; Anne V Kane
Journal:  J Stud Alcohol Drugs       Date:  2014-03       Impact factor: 2.582

3.  Associations Between Body Weight Status and Substance Use Among African American Women in Baltimore, Maryland: The CHAT Study.

Authors:  Ji Li; Cui Yang; Melissa Davey-Rothwell; Carl Latkin
Journal:  Subst Use Misuse       Date:  2016-04-06       Impact factor: 2.164

4.  Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Authors:  Sanjeev K Akkina; Ana C Ricardo; Amishi Patel; Arjun Das; Lydia A Bazzano; Carolyn Brecklin; Michael J Fischer; James P Lash
Journal:  Transl Res       Date:  2012-06-23       Impact factor: 7.012

5.  Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort.

Authors:  Gustavo Zarini; Sabrina Sales Martinez; Adriana Campa; Kenneth Sherman; Javier Tamargo; Jacqueline Hernandez Boyer; Colby Teeman; Angelique Johnson; Abraham Degarege; Pedro Greer; Qingyun Liu; Yongjun Huang; Raul Mandler; David Choi; Marianna K Baum
Journal:  J Womens Health (Larchmt)       Date:  2020-01-31       Impact factor: 2.681

6.  Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.

Authors:  Basmattee Boodram; Michael W Plankey; Christopher Cox; Phyllis C Tien; Mardge H Cohen; Kathryn Anastos; Roksana Karim; Charles Hyman; Ronald C Hershow
Journal:  AIDS Patient Care STDS       Date:  2009-12       Impact factor: 5.078

7.  Hunger and associated harms among injection drug users in an urban Canadian setting.

Authors:  Aranka Anema; Evan Wood; Sheri D Weiser; Jiezhi Qi; Julio Sg Montaner; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-08-26

Review 8.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

9.  Body mass index, immune status, and virological control in HIV-infected men who have sex with men.

Authors:  Aaron J Blashill; Kenneth H Mayer; Heidi M Crane; Chris Grasso; Steven A Safren
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-29

10.  Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.

Authors:  Adam W Carrico; Mallory O Johnson; Stephen F Morin; Robert H Remien; Elise D Riley; Frederick M Hecht; Dietmar Fuchs
Journal:  Brain Behav Immun       Date:  2008-08-03       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.